Hand Foot and Mouth Disease Vaccine (Sun Biotech)

Sun Biotech Pte., Ltd., a Singapore-based biotechnology company, is developing a vaccine candidate for the prevention of Hand Foot and Mouth Disease (HFMD). HFMD is a common and contagious viral illness that primarily affects infants and children, typically characterized by fever, mouth sores, and skin rashes on the hands and feet. As of early 2024, the vaccine is in the preclinical R&D stage of development. While the specific vaccine platform (e.g., inactivated, recombinant, or virus-like particle) and the particular viral strains targeted (such as Enterovirus A71 or Coxsackievirus A16) have not been publicly disclosed, the project is a key component of Sun Biotech's pipeline focused on pediatric and infectious disease immunization.

Other names

HFMD Vaccine